Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
June 2028 116
2028-06
Primary completion PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06445608
2028-06
Study completion Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06499857
2028-06
Primary completion RECOMMEND Platform Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06526533
2028-06
Primary completion Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06672159
2028-06
2028-06
2028-06
2028-06
2028-06
Primary completion Safety of Short-course of NSAIDs in Pediatric Patients With CKD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06860711
2028-06
Study completion TECTONIC CAD IVL IDE Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06885177
2028-06
Primary completion TaVNS for Acute Intracerebral Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06918964
2028-06
2028-06
2028-06
Study completion Study of Human Ocular Hemodynamics by Holography Dopple Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06989996
2028-06
Primary completion Study of Human Ocular Hemodynamics by Holography Dopple Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06989996
2028-06
Study completion CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06994975
2028-06
Study completion Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07021313
2028-06
2028-06
Study completion Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07223593
2028-06
Primary completion Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07223593
2028-06
Study completion A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07239570
2028-06
Primary completion A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07239570
2028-06
2028-06
Primary completion Dronedarone Rhythm Intervention for Early Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07270848
2028-06
Primary completion TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07334691
2028-06
Primary completion Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07338175
2028-06
2028-06
2028-06
Study completion T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07422831
2028-06
2028-06
Study completion Trial Phase: Syndemic Adapted Medly Uganda Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07525271
2028-06
Study completion Patient Quality of Recovery After TAVR With Different Sedation Regimens Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07556523
2028-06
Primary completion Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07654062
2028-06
Primary completion Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07740330
2028-06
Study completion Single-Use Spherical Pulsed Ablation Catheter for Paroxysmal Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07811934
2028-06
2028-06
2028-06-05
2028-06-05
Study completion A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06991257
2028-06-05
2028-06-08
Study completion Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07295522
2028-06-14
Primary completion GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07613437
2028-06-15
Study completion Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07566091
2028-06-16
2028-06-16
2028-06-17
Study completion Prevent Cardiac Surgery Associated AKI Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06620523
2028-06-20
Primary completion Efficacy and Mechanism of Yanjiu Needle for Pharyngeal Dysphagia Based on sEMG Features Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07656025
2028-06-21
2028-06-22
Study completion Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07687186
2028-06-22
Primary completion Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07687186
2028-06-23
Study completion Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05987670
2028-06-23
Primary completion Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled Stethoscope Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05987670
2028-06-25
2028-06-30
Study completion LVAD Conditioning for Cardiac Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03238690
2028-06-30
Primary completion LVAD Conditioning for Cardiac Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03238690
2028-06-30
Study completion Limiting AAA With Metformin (LIMIT) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04500756
2028-06-30
Primary completion Limiting AAA With Metformin (LIMIT) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04500756
2028-06-30
Primary completion Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05180773
2028-06-30
2028-06-30
2028-06-30
2028-06-30
2028-06-30
Primary completion Nectero EAST System Clinical Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06001918
2028-06-30
Study completion Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06092736
2028-06-30
Study completion Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06411327
2028-06-30
Study completion Using AI Systems to Optimize the Clinical Outcome of Stroke Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06828679
2028-06-30
Study completion Efficacy and Safety Study of Isuzinaxib in Subjects With DKD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06962098
2028-06-30
2028-06-30
Primary completion Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07037459
2028-06-30
2028-06-30
2028-06-30
2028-06-30
2028-06-30
Primary completion LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07288398
2028-06-30
Study completion Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07296484
2028-06-30
2028-06-30
Study completion Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07562477
2028-06-30
2028-06-30
Study completion Pro-urokinase for Extended-Window Posterior Circulation Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07617870
2028-06-30
Primary completion HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07721584
2028-06-30
Study completion Ezetimibe for Arrhythmia Recurrence After AF Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07752758
2028-06-30
2028-06-30
Study completion Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07778823
2028-06-30
2028-06-30
2028-06-30
Primary completion Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07846488
July 2028 92
2028-07-01
2028-07-01
2028-07-01
Study completion Unloading in Heart Failure Cardiogenic Shock Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05064202
2028-07-01
Study completion Colchicine Use for Primary Prevention of Coronary Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05175274
2028-07-01
Study completion Folic Acid Supplementation in Calcific Aortic Valve Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05861648
2028-07-01
Study completion Effects of Pioglitazone in Calcific Aortic Valve Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05875675
2028-07-01
2028-07-01
Study completion DCB for CAD With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07009938
2028-07-01
Study completion Safety and Efficacy of J147 in Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07430917
2028-07-01
2028-07-01
Study completion POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07469722
2028-07-01
Primary completion Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07476898
2028-07-01
Primary completion Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07682922
2028-07-01
Primary completion Apixaban Versus Warfarin for Left Ventricular Thrombus Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07709780
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2023-12-30
2023-12-30
2023-12-30
Study completion A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05515393
2023-12-30
Primary completion A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05515393
2023-12-30
Study start Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05700266
2023-12-30
Study start Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05940220
2023-12-30
Study completion Using AR Dental Care Training on Periodontal Status, Blood Sugar Control and QoL in Patients With Type 2 Diabetes Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05993741
2023-12-30
Primary completion Using AR Dental Care Training on Periodontal Status, Blood Sugar Control and QoL in Patients With Type 2 Diabetes Registry record
Expected 2023-12-30; that period ended on 2023-12-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05993741
2023-12
Study completion The Application of a Wireless Sensor Technology for Vital Statistics in CHILDREN AND ADULTS Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01845506
2023-12
Primary completion Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02022293
2023-12
Study completion Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02490306
2023-12
Primary completion Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02490306
2023-12
Primary completion TARGET BP I Clinical Trial Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02910414
2023-12
Study completion Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02988245
2023-12
Study completion Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03021928
2023-12
Primary completion Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03097107
2023-12
Study completion Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03186404
2023-12
Study completion Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03574311
2023-12-31
Study completion Screening for Cancer in Patients With Unprovoked VTE Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03937583
2023-12
Primary completion Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04083339
2023-12-31
Study completion The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04163835
2023-12
Study completion Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04277702
2023-12
2023-12-31
Study completion The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04455178
2023-12-31
Primary completion The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04455178
2023-12-31
Study completion Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04502017
2023-12
Primary completion Magnesium Treating Subarachnoid Hemorrhage Vasospasm Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04613960
2023-12
Primary completion Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04654507
2023-12-31
Study completion Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04664283
2023-12-31
Primary completion Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04664283
2023-12-31
Study completion GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04796428
2023-12-31
Primary completion GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04796428
2023-12-31
Study completion Natural History of COVID-19-Related Atrial Fibrillation Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04830774
2023-12-31
Study completion Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04874051
2023-12-31
Primary completion Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04874051
2023-12-31
Study completion Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04915365
2023-12
Study completion Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04929600
2023-12-31
Study completion Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04967573
2023-12-31
Primary completion Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04984954
2023-12-31
Study completion The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05005741
2023-12-31
Primary completion The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05005741
2023-12
Study completion Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05054842
2023-12
Primary completion Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05054842
2023-12
Study completion An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05089435
2023-12-31
Study completion The Effects of TMZ on Diabetic Nephropathy Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05147194
2023-12-31
Primary completion The Effects of TMZ on Diabetic Nephropathy Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05147194
2023-12-31
Study completion A Digital Solution for Patients With Heart Failure Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05193344
2023-12
Primary completion Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05212597
2023-12-31
Study completion Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05225077
2023-12
Study completion Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05263778
2023-12-31
Study completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05275296
2023-12-31
Primary completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05275296
2023-12
Study completion The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05350124
2023-12
Primary completion The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05350124
2023-12-31
Study completion NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05375110
2023-12
Study completion Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05389254
2023-12-31
Study completion The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF) Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05400928
2023-12
Primary completion A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05415995
2023-12-31
Study completion Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05423626
2023-12-31
Primary completion Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05423626
2023-12
Primary completion VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05443542
2023-12-31
Primary completion Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05500937
2023-12-31
Study completion Prediabetes Management Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05531838
2023-12-31
Primary completion Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05553093
2023-12-31
2023-12-31
2023-12-31
Primary completion CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE) Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05578521
2023-12-31
Study completion Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05700097
2023-12
Study completion Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05836753
2023-12-31
Study completion A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05843162
2023-12-31
Primary completion A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05843162
2023-12-31
Primary completion A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05884502
2023-12
Study completion Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05927766
2023-12
Primary completion Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05927766
2023-12-31
Primary completion Evaluation of the Effectiveness and Safety of ABAStroke Registry record
Expected 2023-12-31; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05979324
2023-12
Primary completion Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05988450
2023-12
Study start Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06129526
2023-12
Study start Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record
Expected 2023-12; that period ended on 2023-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06141980
2024-01-01
Study completion Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management. Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04725526
2024-01-01
Study completion PVP-Guided Decongestive Therapy in HF Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05217342
2024-01-01
Primary completion PVP-Guided Decongestive Therapy in HF Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05217342
2024-01-01
Study completion Echocardiography by Non-cardiologist in Early Management of Patients With Chest Pain Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05306730
2024-01-01
Study start Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide® Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06024525
2024-01-01
Study start Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation Registry record
Expected 2024-01-01; that period ended on 2024-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06166524
2024-01-01
2024-01-03
Primary completion Fluoroscopy Reduction or Elimination in CIED Implants Registry record
Expected 2024-01-03; that period ended on 2024-01-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04919733
2024-01-04
Study completion A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus Registry record
Expected 2024-01-04; that period ended on 2024-01-04.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05759897
2024-01-10
Study completion SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial Registry record
Expected 2024-01-10; that period ended on 2024-01-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05159947
2024-01-10
Primary completion SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial Registry record
Expected 2024-01-10; that period ended on 2024-01-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05159947
2024-01-13
Primary completion ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood Registry record
Expected 2024-01-13; that period ended on 2024-01-13.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06078943
2024-01-15
Study start Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Registry record
Expected 2024-01-15; that period ended on 2024-01-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05702970
2024-01-21
Study completion Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion Registry record
Expected 2024-01-21; that period ended on 2024-01-21.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03827915
2024-01-21
Primary completion Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion Registry record
Expected 2024-01-21; that period ended on 2024-01-21.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03827915
2024-01-30
Study completion ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood Registry record
Expected 2024-01-30; that period ended on 2024-01-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06078943
2024-01
Study completion Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Registry record
Expected 2024-01; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02022293
2024-01
Study completion A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure Registry record
Expected 2024-01; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03082508
2024-01
Study completion Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Registry record
Expected 2024-01; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03097107
2024-01-31
Study completion Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke Registry record
Expected 2024-01-31; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04419337
2024-01
Primary completion Empagliflozin and Atrial Fibrillation Treatment Registry record
Expected 2024-01; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04583813
2024-01-31
Primary completion Evaluation of a Digital Care System in the Follow-Up Care of Atrial Fibrillation Patients Registry record
Expected 2024-01-31; that period ended on 2024-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05375877